Status:
UNKNOWN
Follow-Up of VLBW Infants With Chronic Lung Disease: Respiratory Health and Neurodevelopment
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
National Science and Technology Council, Taiwan
Conditions:
Premature Birth
Eligibility:
All Genders
Up to 3 years
Brief Summary
Although previous studies showed that preterm infants resolving from neonatal respiratory disease are more likely to exhibit respiratory illness, developmental disorders, impaired growth and cognitive...
Detailed Description
The introduction of antenatal steroid use, postnatal surfactant administration and modern respiratory care in the past decade has markedly improved the survival of small preterm infants. However, this...
Eligibility Criteria
Inclusion
- BW below 1,500 gm
- GA under 34 weeks
- Admission to the NTUH and MMH within the first 7 days
Exclusion
- Existence of congenital anomalies and genetic disease
Key Trial Info
Start Date :
August 1 2006
Trial Type :
OBSERVATIONAL
End Date :
July 1 2009
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT00358891
Start Date
August 1 2006
End Date
July 1 2009
Last Update
August 2 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100